171 related articles for article (PubMed ID: 30728339)
1. An Open-Label, Multi-Institutional, Randomized Study to Evaluate the Additive Effect of a Leukotriene Receptor Antagonist on Cough Score in Patients with Cough-Variant Asthma Being Treated with Inhaled Corticosteroids.
Miwa N; Nagano T; Ohnishi H; Nishiuma T; Takenaka K; Shirotani T; Nakajima T; Dokuni R; Kawa Y; Kobayashi K; Funada Y; Kotani Y; Nishimura Y
Kobe J Med Sci; 2018 Dec; 64(4):E134-E139. PubMed ID: 30728339
[TBL] [Abstract][Full Text] [Related]
2. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of montelukast in the treatment of cough variant asthma.
Spector SL; Tan RA
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
[TBL] [Abstract][Full Text] [Related]
4. Comparison of leukotriene receptor antagonists in addition to inhaled corticosteroid and inhaled corticosteroid alone in the treatment of adolescents and adults with bronchial asthma: a meta-analysis.
Cao Y; Wang J; Bunjhoo H; Xie M; Xu Y; Fang H
Asian Pac J Allergy Immunol; 2012 Jun; 30(2):130-8. PubMed ID: 22830292
[TBL] [Abstract][Full Text] [Related]
5. Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
Yi F; Zhan C; Liu B; Li H; Zhou J; Tang J; Peng W; Luo W; Chen Q; Lai K
Respir Res; 2022 Oct; 23(1):279. PubMed ID: 36217131
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
Deykin A; Wechsler ME; Boushey HA; Chinchilli VM; Kunselman SJ; Craig TJ; DiMango E; Fahy JV; Kraft M; Leone F; Lazarus SC; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
Am J Respir Crit Care Med; 2007 Feb; 175(3):228-34. PubMed ID: 16973987
[TBL] [Abstract][Full Text] [Related]
8. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
10. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
11. Effects of the addition of Beta2-agonist tulobuterol patches to inhaled corticosteroid in patients with asthma.
Hozawa S; Haruta Y; Terada M; Yamakido M
Allergol Int; 2009 Dec; 58(4):509-18. PubMed ID: 19700936
[TBL] [Abstract][Full Text] [Related]
12. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
13. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
Bjermer L; Diamant Z
Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
[TBL] [Abstract][Full Text] [Related]
14. [Application of asthma predictive index-based group therapy in wheezing children under 5 years of age].
Li YQ; Xue HY; Chen W; Cao LF
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Aug; 16(8):795-9. PubMed ID: 25140770
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
[TBL] [Abstract][Full Text] [Related]
16. Comparison of inhaled corticosteroids and leukotriene receptor antagonists in adolescents and adults with mild to moderate asthma: a meta-analysis.
Yang D; Luo H; Wang J; Bunjhoo H; Xu Y; Xiong W
Clin Respir J; 2013 Jan; 7(1):74-90. PubMed ID: 22364111
[TBL] [Abstract][Full Text] [Related]
17. Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing.
Ulrik CS; Diamant Z
Clin Exp Allergy; 2010 Apr; 40(4):576-81. PubMed ID: 20128823
[TBL] [Abstract][Full Text] [Related]
18. [Current status of chronic cough treatment in Chinese children].
Clinical Research Coordination Group of the Causes Constituents Ratio of Chronic Cough in Chinese Children
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):163-71. PubMed ID: 24824384
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene D4 inhalation challenge for predicting short-term efficacy of montelukast: a pilot study.
Guan WJ; Shi X; Zheng JP; Gao Y; Jiang CY; Xie YQ; Liu QX; Zhu Z; Guo E; An JY; Yu XX; Liu WT; Zhong NS
Clin Respir J; 2015 Jan; 9(1):111-20. PubMed ID: 24506412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]